| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
7,596,000 | 7,524,000 | 7,212,000 | 6,592,000 | 6,063,967 |
| Cost of Revenue
|
-4,778,000 | -4,665,000 | -4,418,000 | -4,109,000 | -3,850,257 |
|
Gross Profit
|
2,819,000 | 2,859,000 | 2,794,000 | 2,483,000 | 2,213,710 |
| Selling, General and Administrative Expenses
|
-1,051,000 | -1,063,000 | -1,143,000 | -1,266,000 | -1,107,790 |
|
Research and Development Expenses
|
-400,000 | -426,000 | -384,000 | -395,000 | -361,140 |
| Depreciation, Amortization and Depletion
|
-120,000 | -120,000 | -112,000 | -107,000 | -88,057 |
| Other Income/Expense, Operating
|
1,000 | 1,000 | 0 | 3,000 | 22,235 |
|
Operating Income/Expenses
|
-1,570,000 | -1,608,000 | -1,639,000 | -1,765,000 | -1,534,752 |
|
Total Operating Profit/Loss
|
1,249,000 | 1,251,000 | 1,155,000 | 718,000 | 678,958 |
| Total Net Finance Income/Expense
|
-508,000 | -605,000 | -701,000 | -560,000 | -462,665 |
| Net Investment Income
|
-28,000 | -28,000 | -1,000 | 48,000 | 121,720 |
| Irregular Income/Expenses
|
-3,000 | -3,000 | -9,000 | 0 | 0 |
|
Non-Operating Income/Expenses, Total
|
-539,000 | -636,000 | -711,000 | -512,000 | -340,945 |
|
Pretax Income
|
710,000 | 615,000 | 444,000 | 206,000 | 338,013 |
|
Provision for Income Tax
|
-130,000 | -115,000 | -231,000 | -43,000 | -90,111 |
|
Net Income from Continuing Operations
|
580,000 | 500,000 | 213,000 | 163,000 | 247,902 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
580,000 | 500,000 | 213,000 | 163,000 | 247,902 |
|
Non-Controlling/Minority Interests
|
-90,000 | -98,000 | -56,000 | -121,000 | -62,867 |
|
Net Income after Non-Controlling/Minority Interests
|
489,000 | 402,000 | 157,000 | 42,000 | 185,035 |
|
Net Income Available to Common Stockholders
|
489,000 | 402,000 | 157,000 | 42,000 | 185,035 |
|
Diluted Net Income Available to Common Stockholders
|
489,000 | 402,000 | 157,000 | 42,000 | 185,035 |
| Basic EPS
|
0.71 | 0.59 | 0.23 | 0.06 | 0.27 |
| Diluted EPS
|
0.71 | 0.59 | 0.23 | 0.06 | 0.27 |
|
Basic Weighted Average Shares Outstanding
|
685,844.73 | 680,512.57 | 679,668.55 | 679,756.29 | 679,805.14 |
|
Diluted Weighted Average Shares Outstanding
|
686,905.31 | 681,573.15 | 679,916.72 | 679,756.29 | 679,805.14 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,155,000 | 1,157,000 | 1,002,000 | 660,000 | 748,697 |
|
EBITDA
|
1,607,000 | 1,607,000 | 1,440,000 | 1,106,000 | 1,159,677 |
|
Normalized EBITDA
|
1,859,498 | 1,825,100 | 1,494,000 | 1,213,000 | 1,461,589 |
|
Normalized Income
|
582,450.70 | 514,634 | 253,500 | 249,242 | 290,147.25 |
12/31/2022 - 6/2/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade